More Articles
Elutia, a Maryland-based healthcare technology company, has received clearance from the U.S. Food and Drug Administration (FDA) for EluPro, its new biologic envelope specifically designed for patients with…
Kardium, a Canadian medical device company focused on electrophysiology technologies, has raised $104 million in new financing. Fidelity Management and Research Company led the funding round; T. Rowe Price Associates and new investor Durable…
The U.S. Food and Drug Administration (FDA) is warning Americans not to “eat, sell or serve” mushroom-laced chocolates sold by Diamond Shruumz. Sickness and hospitalizations after eating these products have been…
Stuart Connolly, MD, a veteran cardiologist known for his groundbreaking work in the field of electrophysiology, died June 2 after a long battle with neuroendocrine cancer. He was 75 years old.
Connolly spent 40 years at McMaster…
A new pulsed field ablation (PFA) system from Kardium could give cardiologists a new tool in the war against atrial fibrillation (AFib), according to new data published in Heart Rhythm.[1]
The…
WearLinq, a San Francisco-based healthcare technology company, has acquired AMI Cardiac Monitoring, an independent diagnostic testing facility, to help increase the reach of its…
The late-breaking U.S. multicenter admIRE clinical trial at the Heart Rhythm Society 2024 meeting, showed positive data on the long-term safety and effectiveness of the the Biosense Webster Varipulse…
Atraverse Medical, a San Diego-based medical device company focused on left-heart technology, has received U.S. Food and Drug Administration (FDA) clearance for its Hotwire radiofrequency (RF) guidewire.
…Medtronic has added new artificial intelligence (AI) capabilities to its Reveal LINQ insertable cardiac monitor (ICM), the company announced Monday, May 13. The…
…
A total of 21 late-breaking science presentations are scheduled for Heart Rhythm 2024, the annual meeting of the Heart Rhythm Society (HRS). The meeting will take place May 16-19 in Boston.
…




















![Abbott’s Aveir DR leadless pacemaker, the world’s very first dual-chamber pacing solution of its kind, is associated with a “reliable” performance after six months, according to new data published in Heart Rhythm.[1]](/sites/default/files/styles/media_image/public/2024-05/screen_shot_2024-05-10_at_11.33.50_am.png.webp?h=3af9dcd6&itok=ZuCFBzfX)
